Antiviral Activity of Oral Probiotics
NCT05374070 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2022-05-13
Summary
The aim of this study is to test saliva samples obtained from healthy human participants for anti-viral activity after they have consumed S. salivarius probiotic in a powder format.
Conditions
- Lower Respiratory Tract Infection
- Upper Respiratory Tract Infection
Interventions
- DIETARY_SUPPLEMENT
-
Streptococcus salivarius K12 Powder 1 Billion colony forming units /g)
Probiotic Streptococcus salivarius K12 products are commercially available in traditional formats such as lozenges for local delivery in the oral cavity to provide oral health benefits. In this study, a powder formulation will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
- DIETARY_SUPPLEMENT
-
Streptococcus salivarius K12 Powder (1 Billion colony forming units /g) with a prebiotic included
In this study, a powder formulation containing Streptococcus salivarius K12 and a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
- DIETARY_SUPPLEMENT
-
Streptococcus salivarius M18 Powder (1 Billion colony forming units /g)
In this study, a powder formulation will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
- DIETARY_SUPPLEMENT
-
Streptococcus salivarius M18 Powder (1 Billion colony forming units /g) with a prebiotic included
In this study, a powder formulation containing S. salivarius M18 and a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
Sponsors & Collaborators
-
John Hale
lead INDUSTRY
Principal Investigators
-
John D Hale, PhD · Blis Technologies Ltd, Dunedin, New Zealand
-
John R Tagg, PhD · Blis Technologies Ltd, Dunedin, New Zealand
-
Liam Harold, PhD · Blis Technologies Ltd, Dunedin, New Zealand
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-23
- Primary Completion
- 2022-06-23
- Completion
- 2022-08-15
Countries
- New Zealand
Study Locations
More Related Trials
-
Study to Investigate the Treatment Benefits of Probiotic Streptococcus Salivarius K12 for Hospitalised Patients (Non-ICU) With COVID-19
NCT05043376 ·Status: COMPLETED ·Phase: NA
-
Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19
NCT05175833 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children
NCT05577065 ·Status: COMPLETED ·Phase: NA
-
The Probiotic for Oral Health (PRO Health) Study
NCT03748017 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease).
NCT04937556 ·Status: COMPLETED ·Phase: NA
-
Probiotics and Influenza Vaccination Response
NCT05690373 ·Status: COMPLETED ·Phase: NA
-
Probiotics in Children With Early Childhood Caries
NCT03998306 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections
NCT00599430 ·Status: COMPLETED ·Phase: NA
-
The Effect of Synbiotics on the Upper Respiratory Tract Infection
NCT04960878 ·Status: COMPLETED ·Phase: NA
-
The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19
NCT04734886 ·Status: COMPLETED ·Phase: NA
-
The Impact of Compound Probiotic Freeze-dried Powder on Enhancing Gastrointestinal Health
NCT07025798 ·Status: COMPLETED ·Phase: NA
-
Levilactobacillus Brevis Oral Health
NCT06457724 ·Status: COMPLETED ·Phase: NA
-
Development and Evaluation of Functional Probiotic Powder in Human Trials
NCT06760468 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Probiotic and Zinc Supplementation on the Common Cold
NCT04672850 ·Status: UNKNOWN ·Phase: NA
-
Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients
NCT04907877 ·Status: COMPLETED ·Phase: NA
-
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
NCT01479478 ·Status: COMPLETED ·Phase: NA
-
Examining the Effects of One-Month Probiotic Treatment on Mental Fatigue
NCT03611478 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19
NCT04621071 ·Status: COMPLETED ·Phase: NA
-
Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health
NCT03543982 ·Status: COMPLETED ·Phase: NA
-
Probiotic S. Salivarius K12 for the Prevention of Upper Respiratory Tract Infection in Nursery-age Children
NCT05840926 ·Status: COMPLETED ·Phase: NA
-
Determining the Viability a Lozenge Dosage for Probiotics
NCT06819761 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Salivary IgA and Cytokines Response to Dietary Supplementation of Lactobacillus Reuteri
NCT02017886 ·Status: COMPLETED ·Phase: NA
-
Probiotic, Prebiotic and Synbiotic Effect on Immunity
NCT01084434 ·Status: UNKNOWN ·Phase: NA
-
Analysis of the Gut Microbiota Composition After Consumption of Probiotic Bacteria
NCT07046897 ·Status: RECRUITING ·Phase: NA
-
Safety of an Oral Probiotic in Healthy Adults
NCT04492631 ·Status: COMPLETED ·Phase: NA